New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2014
07:59 EDTROSGRosetta Genomics platform predicts bladder cancer progression in published study
Rosetta Genomics announces the publication of clinical data in an article entitled, "The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer." The study profiled and analyzed microRNA expression levels in 86 samples of non-muscle-invasive bladder cancer to identify patterns of expression that are indicative of a high probability of disease progression. The main finding showed that in the least invasive tumors, low expression levels of miR-10a are correlated to later recurrence of the disease in a more invasive form. According to study author, Ulrika Segersten, Ph.D., Department of Surgical Sciences, Uppsala University, Uppsala, Sweden, "Profiling revealed that certain microRNAs predicted the risk of developing higher stage among patients with Ta cancers. Lower miR-10a-5p expression in Ta progressing tumors indicates that this microRNA could have a crucial role for later invasion of non-invasive bladder tumors."
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
08:32 EDTROSGRosetta Genomics announces data published in Leukemia Research
Subscribe for More Information
April 17, 2015
10:00 EDTROSGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: CECO Environmental (CECE) upgraded on several positive catalysts at Roth Capital... EMC (EMC) upgraded to Outperform from Market Perform at Bernstein... Fleetmatics (FLTX) upgraded to Overweight from Neutral at Piper Jaffray... NorthStar Asset Management (NSAM) upgraded to Buy from Hold at MLV & Co.... Penn National (PENN) upgraded to Overweight from Neutral at JPMorgan... Rosetta Genomics (ROSG) upgraded to Buy from Hold at Cantor... Ulta Salon (ULTA) upgraded to Buy from Neutral at Nomura... Xcel Energy (XEL) upgraded to Buy from Hold at Argus.
09:14 EDTROSGOn The Fly: Pre-market Movers
Subscribe for More Information
06:33 EDTROSGRosetta Genomics upgraded to Buy from Hold at Cantor
Subscribe for More Information
April 16, 2015
11:16 EDTROSGRosetta Genomics receives patent allowance for cancer of origin diagnostic assay
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use